Neuroklinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,360 | 2,390 | 2,490 | 6,500 | 5,575 | 1,025 | 2,635 | 6,050 |
| Profit before tax | 1,053 | 3,966 | -469 | 3,242 | - | - | - | - |
| Net profit | 1,053 | 3,966 | -469 | 3,242 | 1,897 | -2,871 | -1,725 | 510 |
| Equity | -49,676 | -45,710 | -46,179 | -42,937 | -41,040 | -43,910 | -45,636 | -45,125 |
| Liabilities | 51,048 | 48,260 | 47,969 | 47,534 | 46,607 | 46,716 | 46,774 | 46,796 |
| Non-current assets | 1 | 1 | 1 | 0 | 0 | 0 | 1,118 | 0 |
| Current assets | 1,351 | 2,528 | 1,769 | 4,560 | 5,387 | 2,569 | 0 | 1,650 |
| Total assets | 1,352 | 2,529 | 1,770 | 4,560 | 5,387 | 2,569 | 1,118 | 1,650 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 457 | 599 | 704 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +5.3% | -55.4% | +4.2% | +161.0% | -14.2% | -81.6% | +157.1% | +129.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 77.9% | 156.8% | -26.5% | 71.1% | 35.2% | -111.8% | -154.3% | 30.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 19.6% | 165.9% | -18.8% | 49.9% | 34.0% | -280.1% | -65.5% | 8.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 19.6% | 165.9% | -18.8% | 49.9% | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,787 | 1,147 | 1,245 | 3,250 | 2,788 | 513 | 1,318 | 2,689 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neuroklinika - Social security debts
The company had no debts to Sodra
Neuroklinika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neuroklinika, UAB (code 300575032) is a Private Limited Liability Company operating in medical specialists activities. In the latest financial year, 2025, the company generated €6.0K in revenue, up 129.6% year on year and 490.2% over two years. After losses of €2.9K in 2023 and €1.7K in 2024, it returned to a net profit of €510 in 2025, lifting the profit margin to 8.4%. The three-year trend shows a steady increase in turnover and a gradual improvement in profitability, although the business remains very small in scale.
The balance sheet remains tight. Total assets were €1.6K in 2025, while liabilities stood at €46.8K and equity remained negative at €45.1K. This indicates that liabilities continued to substantially exceed the company’s asset base and that the equity position stayed under pressure. Asset turnover reached 3.67x in 2025, suggesting relatively efficient use of a limited asset base. Revenue per employee was €3.0K and profit per employee €255, pointing to low absolute productivity levels consistent with the company’s small revenue base.
The balance sheet remains tight. Total assets were €1.6K in 2025, while liabilities stood at €46.8K and equity remained negative at €45.1K. This indicates that liabilities continued to substantially exceed the company’s asset base and that the equity position stayed under pressure. Asset turnover reached 3.67x in 2025, suggesting relatively efficient use of a limited asset base. Revenue per employee was €3.0K and profit per employee €255, pointing to low absolute productivity levels consistent with the company’s small revenue base.